Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9603)
All Articles published online
|
Publishing Process of This Article
|
Nov 14, 2019 (publication date) through Jan 25, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Elemeery MN, Mohamed MA, Madkour MA, Shamseya MM, Issa NM, Badr AN, Ghareeb DA, Pan CH. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes. World J Gastroenterol 2019; 25(42): 6322-6341 [PMID: 31754293 DOI: 10.3748/wjg.v25.i42.6322] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v25/i42/6322.htm |
| Number | Citing Articles |
| 1 |
Jia-Kai Jiang, Han-Shen Chen, Wei-Feng Tang, Yu Chen, Jing Lin. Rs3746444 T>C locus in miR-499 increases the susceptibility to hepatocellular carcinoma: A meta-analysis 14812 subjects. World Journal of Gastrointestinal Oncology 2023; 15(1): 171-185 doi: 10.4251/wjgo.v15.i1.171
|
| 2 |
Pankhuri Kaushik, Arun Kumar. Emerging role and function of miR-198 in human health and diseases. Pathology - Research and Practice 2022; 229: 153741 doi: 10.1016/j.prp.2021.153741
|
| 3 |
Xu Qian, Yongwei Jiang, Yadi Yang, Yukun Zhang, Na Xu, Bin Xu, Ke Pei, Zhi Yu, Wei Wu. Recent advances of miR-23 in human diseases and growth development. Non-coding RNA Research 2025; 11: 220 doi: 10.1016/j.ncrna.2024.12.010
|
| 4 |
Felipe Padilla-Martinez, Gladys Wojciechowska, Lukasz Szczerbinski, Adam Kretowski. Circulating Nucleic Acid-Based Biomarkers of Type 2 Diabetes. International Journal of Molecular Sciences 2021; 23(1): 295 doi: 10.3390/ijms23010295
|
| 5 |
Chengdong Wang, Feng Li, Linhua Deng, Mingzhou Li, Ming Wei, Bo Zeng, Kai Wu, Zhongxian Xu, Rongping Wei, Limin Wei, Weiping Liu, Siyuan Zhang, Lin Xu, Yan Huang, Desheng Li, Ying Li, Hemin Zhang. Identification and characterization of miRNA expression profiles across five tissues in giant panda. Gene 2021; 769: 145206 doi: 10.1016/j.gene.2020.145206
|
| 6 |
Lucas Trevisan França de Lima, Daniel Broszczak, Xi Zhang, Kim Bridle, Darrell Crawford, Chamindie Punyadeera. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(2): 188451 doi: 10.1016/j.bbcan.2020.188451
|
| 7 |
Justyna Żychowska, Maciej Ćmil, Patryk Skórka, Joanna Olejnik-Wojciechowska, Paulina Plewa, Estera Bakinowska, Kajetan Kiełbowski, Andrzej Pawlik. The Role of Epigenetic Mechanisms in the Pathogenesis of Hepatitis C Infection. Biomolecules 2024; 14(8): 986 doi: 10.3390/biom14080986
|
| 8 |
Kwang-Hoon Chun. Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma. Pharmaceutics 2022; 14(7): 1380 doi: 10.3390/pharmaceutics14071380
|
| 9 |
Simona Cernea, Danusia Onișor. Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma. World Journal of Gastroenterology 2023; 29(2): 286-309 doi: 10.3748/wjg.v29.i2.286
|
| 10 |
Robin Zenlander, Hugh Salter, Stefan Gilg, Gösta Eggertsen, Per Stål. MicroRNAs as Plasma Biomarkers of Hepatocellular Carcinoma in Patients with Liver Cirrhosis—A Cross-Sectional Study. International Journal of Molecular Sciences 2024; 25(4): 2414 doi: 10.3390/ijms25042414
|
| 11 |
Yanan Jiang, Xiuyun Shen, Moyondafoluwa Blessing Fasae, Fengnan Zhi, Lu Chai, Yue Ou, Hai Feng, Siwei Liu, Ying Liu, Shucai Yang, Maria Isaguliants. The Expression and Function of Circadian Rhythm Genes in Hepatocellular Carcinoma. Oxidative Medicine and Cellular Longevity 2021; 2021(1) doi: 10.1155/2021/4044606
|
| 12 |
Andre Broermann, Ramona Schmid, Ogsen Gabrielyan, Marlene Sakowski, Claudia Eisele, Sascha Keller, Michael Wolff, Patrick Baum, Birgit Stierstorfer, Jochen Huber, Bernhard K. Krämer, Berthold Hocher, Ruediger Streicher, Denis Delić. Exosomal miRNAs as Potential Biomarkers to Monitor Phosphodiesterase 5 Inhibitor Induced Anti-Fibrotic Effects on CCl4 Treated Rats. International Journal of Molecular Sciences 2020; 22(1): 382 doi: 10.3390/ijms22010382
|
| 13 |
Xiaojie Yu, Hannah Eischeid-Scholz, Lydia Meder, Vangelis Kondylis, Reinhard Büttner, Margarete Odenthal. SQSTM1/p62 promotes miR-198 loading into extracellular vesicles and its autophagy-related secretion. Human Cell 2022; 35(6): 1766 doi: 10.1007/s13577-022-00765-7
|
| 14 |
Jingwen Yang, Weiwei Dong, He Zhang, Huixia Zhao, Zhiyan Zeng, Fengyun Zhang, Qiuwen Li, Xiaohong Duan, Yanyan Hu, Wenhua Xiao. Exosomal microRNA panel as a diagnostic biomarker in patients with hepatocellular carcinoma. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.927251
|
| 15 |
Tingting Shi, Hideki Kobara, Kyoko Oura, Tsutomu Masaki. Mechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 Diabetes. Journal of Hepatocellular Carcinoma 2021; : 45 doi: 10.2147/JHC.S274933
|
| 16 |
Julie Sanceau, Angélique Gougelet. Clinical Applications of Non-Coding RNAs in Cancer. 2022; : 343 doi: 10.1016/B978-0-12-824550-7.00007-2
|
| 17 |
Khaoula Errafii, Amin Jayyous, Abdelillah Arredouani, Hasan Khatib, Fouad Azizi, Ramzi M. Mohammad, Muhammad Abdul-Ghani, Mohamed Chikri. Comprehensive analysis of circulating miRNA expression profiles in insulin resistance and type 2 diabetes in Qatari population. All Life 2022; 15(1): 191 doi: 10.1080/26895293.2022.2033853
|
| 18 |
Maria Corina Plaz Torres, Giorgia Bodini, Manuele Furnari, Elisa Marabotto, Patrizia Zentilin, Mario Strazzabosco, Edoardo G. Giannini. Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective?. Cancers 2020; 12(6): 1422 doi: 10.3390/cancers12061422
|
| 19 |
Rodolfo Mastropasqua, Rossella D’Aloisio, Erica Costantini, Annamaria Porreca, Giada Ferro, Daniele Libertini, Marcella Reale, Marta Di Nicola, Pasquale Viggiano, Gennaro Falconio, Lisa Toto. Serum microRNA Levels in Diabetes Mellitus. Diagnostics 2021; 11(2): 284 doi: 10.3390/diagnostics11020284
|
| 20 |
Yuhua Mai, Liheng Meng, Ganlu Deng, Yingfen Qin. The Role of Type 2 Diabetes Mellitus–Related Risk Factors and Drugs in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2024; : 159 doi: 10.2147/JHC.S441672
|
| 21 |
Qinghua Peng, Xiaoning Zhu, Yuanyuan Jiang, Mengyun Peng, Ding Zheng, Xiaodong Wang, Yoke Kqueen Cheah, Jing Wang. Evaluating the roles of microRNAs associated with nonalcoholic fatty liver disease in hepatocellular carcinoma tumorigenesis: a systematic review and network analysis. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1462513
|
| 22 |
Ali Mahmoudi, Amin Jalili, Alexandra E. Butler, Seyed H. Aghaee-Bakhtiari, Tannaz Jamialahmadi, Amirhossein Sahebkar. Exploration of the Key Genes Involved in Non-alcoholic Fatty Liver Disease and Possible MicroRNA Therapeutic Targets. Journal of Clinical and Experimental Hepatology 2024; 14(4): 101365 doi: 10.1016/j.jceh.2024.101365
|